Kairui Innovation

Kairui Innovation Pharmaceutical Technology (Kairui Innovation) is a research-driven biotechnology company based in Beijing, China, specializing in the discovery and development of novel small molecule therapeutics. Founded in 2012, the company leverages an integrated drug discovery platform that combines computer-aided drug design (CADD) with advanced medicinal chemistry and pharmacology. Kairui Innovation focuses on high-value targets within the metabolic, oncological, and immunological therapeutic areas, maintaining both a proprietary internal pipeline and a suite of high-end CRO services. Their business model emphasizes the rapid optimization of lead compounds and the advancement of drug candidates from discovery into early-stage clinical development through strategic partnerships with domestic and international pharmaceutical firms.